Heart care, connected
Uniting patients, care teams, and researchers on a secure, technology-enabled platform that drives clinical innovation and offers a path towards better patient outcomes.
Learn moreBridging the gap between day‑to‑day patient care and cutting‑edge clinical research
We believe meaningful data transforms the pace of drug development and shapes better treatment decisions. Our FDA‑cleared software collects real‑world clinical data and applies advanced algorithms to give physicians, researchers, and innovators the clarity they need to accelerate cardiology breakthroughs so patients receive better outcomes.

Prolaio’s high-density data approach
By uniting patients, providers, and researchers on a single, intuitive platform, we’re enabling proactive care, simplifying research workflows, and delivering the kind of high‑density, clinical insights that drive true 21st‑century innovation in cardiology.
Learn moreHow Prolaio helps
Patients
Continuous insight into your heart health, keeping you and your care team connected - no matter where you are.
Care teams
Meaningful longitudinal data, synthesized into clinical insights toward better treatment decisions.
Clinical researchers
High-density data to optimize study design, reduce overhead, and increase confidence in your results.

Heart disease is a serious problem for patients and healthcare systems
#1
Heart disease is the leading cause of death for people in the United States.
$1 billion per day
Economic toll on US ($595M direct costs, $405M lost productivity)
33 seconds
One person dies every 33 seconds in the United States from cardiovascular disease.
1.3 million
Heart failure is the most common and expensive reason for preventable hospital stays – 1.3 million US hospitalizations annually.
Unmatched platform
4M+
Hours of on-body patient data
20+
Issued patents
5
FDA-cleared algorithms
26+
Countries served
40+
Proven algorithms
30+
Years of experience in machine learning



Better heart health
We're creating smarter ways to help solve the challenges of heart disease.
We envision a future where care teams and hospitals are more effective, the healthcare system is more efficient, researchers have greater confidence in their trials, and new drugs accelerate to market—so more patients have access to better care, improved outcomes, and healthier lives.
This is precision cardiology, and we know it’s within reach.